FDA.reportPublic FDA data

AHA BHA Blemish Control and Exfoliating Serum

Manufacturer
Banuskin, Inc.
Effective date
2025-04-03
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 00:59:13

Label at a glance#

ProductAHA BHA Blemish Control and Exfoliating Serum
Active ingredientSALICYLIC ACID
Label structure13 sections

Indications and uses

For the treatment of acne

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid 2.0%

Purpose

OTC - PURPOSE SECTION

Acne Treatment

Uses

INDICATIONS & USAGE SECTION

For the treatment of acne

Warnings

WARNINGS SECTION

For external use only

When using this product

OTC - WHEN USING SECTION

When using this product • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Direction

INSTRUCTIONS FOR USE SECTION

  • Cleanse skin thoroughly before applying product.
  • Cover the entire affected area with a thin layer one to three times daily.
  • Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor.
  • if bothersome dryness or peeling occurs, reduce application to once a day or every other day.

Other Information

OTHER SAFETY INFORMATION

Sunburn Alert: This product contains an alpha hydroxy acid (AHA) that may increase your skin's sensitivity to the sun and particularly the possibility of sunburn. Use a sunscreen, wear protective clothing, and limit sun exposure while using this product and for a week afterwards.

Inactive Ingredient

INACTIVE INGREDIENT SECTION

Aqua/Water/Eau, Isopentyldiol, Squalane, Dipropylene Glycol, Hydroxypropyl Starch Phosphate, Mandelic Acid, Niacinamide, Sodium Hydroxide, Citric Acid, Succinic Acid, Phenoxyethanol, Lactobacillus ferment lysate, Xanthan Gum, Alpha-glucan oligosaccharide, Hydrogenated Lecithin, Sclerotium Gum, Lecithin, Pullulan, Allantoin, Bisabolol, Sodium Phytate, Potassium Sorbate, Sodium Benzoate, Silica, 1,2-Hexanediol, Hydroxyacetophenone, Sodium Hyaluronate, Ethylhexylglycerin.

Questions or comments?

OTC - QUESTIONS SECTION

Questions or comments?

www.banuskin.com

855-215-2268

DOSAGE & ADMINISTRATION SECTION

Topical Liquid (Serum)

SPL UNCLASSIFIED SECTION

banu

AHA + BHA BLEMISH CONTROL & EXFOLIATING SERUM

2% Salicylic Acid

Acne Treatment

SAFE FOR ACNE-PRONE SKIN

30 mL/1 fl.oz

Labels

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

30 mL Bottle Carton

Serum-boxSerum-box

30 mL Bottle Serum-prySerum-pry

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
251577salicylic acid 2 % Topical SolutionPSN1
251577salicylic acid 20 MG/ML Topical SolutionSCD1
251577salicylic acid 2 % Topical SolutionSY1

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
dea2eded-d1e7-46bb-9a3d-f8dc20de6277Product name120190408

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
85439-0101-1AHA BHA Blemish Control and Exfoliating Serum30 mL in 1 BOTTLE, PUMPLIQUID301

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
85439-0101AHA BHA BLEMISH CONTROL AND EXFOLIATING SERUM (SALICYLIC ACID SERUM) LIQUID [BANUSKIN, INC.]1Current NDC, 1 package rows20250417_31e47495-a9fa-a9e8-e063-6294a90a6b67.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 28 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
85439-010185439-0101-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 26 matching rows.

Name, UNII, Kind table
NameUNIIKind
SALICYLIC ACIDO414PZ4LPZACTIB
NIACINAMIDE25X51I8RD4IACT
CITRIC ACID2968PHW8QPIACT
XANTHAN GUMTTV12P4NEEIACT
PHENOXYETHANOLHIE492ZZ3TIACT
HYDROXYACETOPHENONEG1L3HT4CMHIACT
ISOPENTYLDIOL19NOL5474QIACT
SQUALANEGW89575KF9IACT
HYDROXYPROPYL STARCH9M44R3409AIACT
SODIUM HYDROXIDE55X04QC32IIACT
PULLULAN8ZQ0AYU1TTIACT
BISABOLOL24WE03BX2TIACT
POTASSIUM SORBATE1VPU26JZZ4IACT
ALPHA-GLUCAN OLIGOSACCHARIDES95658MI3WIACT
SODIUM BENZOATEOJ245FE5EUIACT
SILICON DIOXIDEETJ7Z6XBU4IACT
SODIUM HYALURONATEYSE9PPT4THIACT
WATER059QF0KO0RIACT
MANDELIC ACIDNH496X0UJXIACT
SODIUM PHYTATE88496G1ERLIACT
1,2-HEXANEDIOLTR046Y3K1GIACT
DIPROPYLENE GLYCOLE107L85C40IACT
SUCCINIC ACIDAB6MNQ6J6LIACT
SCLEROTIUM GUM2X51AD1X3TIACT
ALLANTOIN344S277G0ZIACT
ETHYLHEXYLGLYCERIN147D247K3PIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AHA BHA Blemish Control and Exfoliating SerumSALICYLIC ACID SERUMBanuskin, Inc.31e47495-a9fa-a9e8-e063-6294a90a6b672025-04-03WarningsExact identifier
ndc (package): 85439-0101-1
ndc (product): 85439-0101
ndc11 (package): 85439010101
spl id: 31e47495-a9fb-a9e8-e063-6294a90a6b67
spl set id: 31e47495-a9fa-a9e8-e063-6294a90a6b67

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.